University of Alberta

Edmonton, Alberta T6g2b7

10 studies enrolling now · 215 studies all time

What they study most

ALS, AML, Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Kidney Injury, Acute Liver Failure, Acute Liver Injury, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Alcoholism

Studies at this site

Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. — Recruiting now
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Recruiting now
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study) — Recruiting now
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) — Recruiting now
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. — Recruiting now
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection — Recruiting now
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
Nerve Transfer to Improve Function in High Level Tetraplegia — Recruiting now
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study — Recruiting now
Fecal Microbiota Transplant National Registry — Recruiting now
Effects of 5HTP on the Injured Human Spinal Cord — Recruiting now
Testicular Evaluation of Azoospermia Using Micro-Ultrasound — Recruiting now
Study of Bitopertin in Participants With EPP or XLP (APOLLO) — Running, not enrolling
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa — Running, not enrolling
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) — Running, not enrolling
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers — Completed
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System — Completed
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis — Running, not enrolling
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib — Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates — Running, not enrolling
Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT — Completed
Nerve Transfer After Spinal Cord Injury- Multi-center — Running, not enrolling
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) — Running, not enrolling
Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program — Running, not enrolling
Study Evaluating Subjects With Distal Renal Tubular Acidosis — Stopped early
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL — Running, not enrolling
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis — Running, not enrolling
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis — Running, not enrolling
The Acute Burn ResUscitation Multicenter Prospective Trial — Completed
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease — Running, not enrolling
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy — Stopped early
A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema — Completed
Novel MRI Biomarkers for Monitoring Disease Progression in ALS — Running, not enrolling
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) — Completed
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy — Completed
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension — Completed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia — Completed
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
Women's Heart Attack Research Program: Stress Ancillary Study — Completed
Heart Attack Research Program- Imaging Study — Running, not enrolling
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System — Running, not enrolling
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) — Running, not enrolling